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EXPERIMENTAL STUDIES 
Abstract: Most xenobiotics and carcinogens are metabolized primarily by the hepatic drug-metabolizing 
enzymes including cytochrome P450, cytochrome b5, arylhydrocarbon hydroxylase (AHH), and 
dimethylnitrosamine N-demethylase I (DMN-dI) as phase I drug-metabolizing enzymes. Therefore, changes in 
the activities of the above mentioned enzymes as well as free radical levels measured as thiobarbituric acid 
reactive substances [TBARS] were determined in the livers of sixty mice pretreated with glutathione [100 
mg/kg], as antioxidant, before intraperitoneal administration of dimethylnitrosamine [DMN] [10 mg/kg], 
diethylnitosamine [DEN] [10 mg/kg], or methylpropylnitrosamine [MPN] [10 mg/kg] for seven consecutive 
days. Ten control animals received distilled water as vehicle for comparison with treated animals. The hepatic 
content of cytochrome P450 induced after treatment of mice with DMN, DEN and MPN while DMN, DEN, or 
MPN increased AHH activity. Also, cytochrome b5 content and DMN-N-dI induced after treatment with DMN 
or DEN. Interestingly, glutathione pretreatment restored the activities of the previously mentioned enzymes 
caused by DMN or DEN. On the other hand, DMN, DEN, and MPN depleted the levels of glutathione, and 
increased the levels of free radicals [TBARS]. DMN and DEN increased the activity of GST. Interestingly, 
pretreatment of mice with glutathione before administration of DMN, or DEN was found to restore the levels of 
TBARS and GSH to their normal levels. In addition, GSH pretreatments induced the activity of GST above the 
normal levels after administration of DMN or MPN except DEN did not change such activity. It was concluded 
that N-nitrosamines enhanced the activity of phase I & II carcinogen-metabolizing enzymes as well as increased 
the production of free radicals. The mechanism by which GSH restores the activity of carcinogen-metabolizing 
enzymes or free radical production to their normal levels is possibly due to induction of GST activity and/or a 
direct binding to the xenobiotic molecules.
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Introduction
N-nitrosamines are carcinogenic compounds that occur widely in the environment and 
can be formed endogenously from the interaction of ingested nitrate or nitrite with secondary 
amines [1]. In fact, dimethylnitrosamine (DMN) could be formed in food products and causes 
acute hepatotoxic effects [2]. DMN is the most encountered volatile nitrosamine in the highest 
concentrations in food samples and beverages [3]. Evidence for the presence of urinary N-
nitrosamines has been obtained for different populations from widely separate regions of the 
world in order to establish the link between exposures to this group of chemical carcinogens and 
different types of cancer. Subjects with high-risks of developing stomach, esophageal, colon and 
urinary bladder cancers were found to excrete higher levels of N-nitrosamines in their urine 
compared to their relevant low-risk control groups [4-6]. Their role as causative agents in the 
carcinogenesis of some human neoplastic diseases has been extensively reviewed [7-9]. N-
nitrosamines are activated by N-nitrosodimethylamine-N-demethylases I & II (NDMA dI & dII) 
in order to exert their cytotoxic and carcinogenic effects [10, 11]. Following the N-demethylation 
by NDMA, a diazonium ion is produced leading ultimately to the formation of carbonium ion 
that can methylate DNA. It was suggested that the carcinogenic effects of N-nitrosamines are 
proportional to the activities of their activating enzymes since more of the active metabolites 
might be produced when the demethylases are activated [12]. 
The hepatic cytochromes P450s (CYP) are a multigene family of enzymes that play a 
critical role in the metabolism of many drugs and carcinogens [13]. Cytochrome P450 activates
polycyclic aromatic hydrocarbons (PAHs) into more reactive intermediates that covalently bind 
to DNA, a key event in the initiation of carcinogenesis [14, 15]. An important and extensively 
studied member of PAHs is benzo (a) pyrene (B (a) P), which has been shown to cause 
cytotoxic, mutagenic and carcinogenic effects in tissues from various animal species [16-19]. It has 
been reported that the carcinogenic potency of B (a) P is well correlated with the induction of 
aryl hydrocarbon hydroxylase (AHH) activity and cytochrome P450 1A1 [17, 20]. AHH activity 
can be induced by a wide variety of xenobiotics, drugs, carcinogens, and parasites [12, 13, 21] and, 
can therefore play an important role in human carcinogenesis [18].
The cytosolic glutathione-S-transferase (GST) and GSH play an important role in the 
detoxification of many environmental chemicals including mutagens and carcinogens [22]. 
Previous studies have demonstrated that GST reduced the covalent binding of epoxides of well 
known chemical carcinogens with DNA [23, 24]. In addition, GSH can directly react with and 
inactivate toxic electrophiles in the diet [25-27.]. Previous studies have shown that consumption of 
food high in GSH content is associated with about 50% reduction in the risk of oral and 
pharyngeal cancer [28]. Induction of GST was found to be effective in decreasing the 
hepatocarcinogenesis caused by carcinogenic compounds [23, 24]. Inducers of GSTs are generally 
considered as protective compounds against cancer. The human diet contains many compounds 
that inhibit various steps of the carcinogenic process. The coffee specific diterpenses cafestol 
and kahweol have been reported to be anti-carcinogenic in several animal models.  It has been
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postulated that this activity may be related to their ability to induction of glutathione S-
transferase [22,29]. GST was induced in the stomach by coumarin and Į-angelicalactone and in the 
pancrease by flavone. Several dietary compounds have been demonstrated to reduce 
gastrointestinal cancer rates in both human and animals. For example, sulforaphane, indole-3-
carbinol, D-limonene and relafen induced GST levels in small intestine, livers, and stomach [30]. 
Aqueous extracts of either green or black tea induced GST and UDP-Glucuronyl transferase 
after administration to rats as the sole drinking fluid for 4 weeks [31, 32]. 
It is considered that generation of free radicals and induction of carcinogen-metabolizing 
enzymes play a critical step in initiation of carcinogenesis [13, 22]. No previous studies have been 
conducted on the influence of N-nitrosamines on the activity of carcinogen metabolizing 
enzymes as well as free radical levels after pretreatment of male mice with glutathione as 
antioxidant. Therefore, the present study was planned to investigate the effect of N-nitrosamines 
on the contents of cytochrome P450 and cytochrome b5 and the activity of AAH, NDMA-dI, 
and, glutathione S-transferase, as well as reduced glutathione, and the levels of free radicals after 
pretreatment of male mice with glutathione.
Subjects and Methods
Glutathione, bis-(3-carboxy-4-nitophenyl)-disulfide, thiobarbituric acid, and 1-chloro-2,4-
dinitrobenzene, glucose-6-phosphate; glucose-6-phosphate dehydrogenase Type XV from Baker 
Yeast; nicotinamide adenine dinucleotide phosphate (NADP), dimethylnitrosamine, 
diethynitrosamine, and methylpropylnitrosamine and other reagents were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Benzo (a) pyrene was obtained from Koch-Light 
Laboratories, UK. Carbon tetrachloride was obtained from Merck, Darmstadt. Seventy male 
mice weighing 20-25 g were used throughout the study. The local ethics committee approved the 
design of the experiments, and the protocol conforms to the guidelines of the NIH. Animals 
were housed five animals per cage where food and water were provided ad libitum. Glutathione 
[100 mg/kg body weight] administered to mice by an hour earlier before injection of 
dimethylnitrosamine [10 mg/kg], diethylnitrosamine [10 mg/kg], or methylpropylnitrosamine 
[10 mg/kg]. GSH and various N-nitrosamines were administered intraperitonealy to male mice 
for seven consecutive days. Ten control animals received distilled water as vehicle and assayed 
with treated animals. Liver tissues were dissected into very small pieces before homogenization 
in 3 volumes of 0.1 M of potassium phosphate buffer, pH 7.4. After centrifugation at 12,000 g 
for 20 min at 4ºC, the supernatant fractions were divided into two unequal volumes. A small 
volume (25% of the supernatant) was kept at 4ºC for assaying the levels of glutathione and 
thiobarbituric acid-reactive substances and the activity of glutathione S-transferase. The larger 
volume was centrifuged at 105,000 g for 1 h at 4 ºC to yield a microsomal pellet which was then 
resuspended in 0.1 M potassium phosphate buffer, pH 7.4.
J T U Med Sc 2006; 1(1)
75
Sheweita
The total microsomal content of cytochrome P450 was determined using the molar 
extinction coefficient 91 mM-1cm-1 for the reduced cytochrome P-450-carbon monoxide 
complex and 185 mM-1 cm-1 for reduced cytochrome b5 [33]. Microsomal AHH activity was 
determined according to the method of Wiebel and Gelboin [34];  briefly,  the incubation mixture 
(total volume1ml) contained 50 mM Tris-HCl buffer, pH 7.4; 3 μmole MgCl2; 0.6 mole 
NADPH; 100 nmole benzo(a)pyrene; 0.1ml of microsomal protein (10 mg/ml) and the reaction 
was incubated at 37 ºC for 10 min. It was terminated by the addition of 1 ml acetone. The 3-
hydroxy benzo (a) pyrene was extracted in 2 ml hexane for measurement of the fluorescence 
intensity at excitation and emission wavelengths of 396 and 522 nm, respectively.
Microsomal NDMA-dI activity was determined according to the method of Venkatesan 
et al [35] with the modification of Mostafa and Sheweita 1992, using a substrate concentration of 
4 mM NDMA, which represents the saturation level for this enzyme. The incubation mixture 
(total volume 3 ml) contained 6 μmole MgCl2; 12 μmole niacinamide; 0.1 M potassium 
phosphate buffer pH 7.4; 0.4 ml KCl (1.15%); 12 μmole glucose-6-phosphate; 1 unit glucose-6-
phosphate dehydrogenase Type XV from Bakers Yeast; 1.2 μmole NADP and 0.25 ml 
microsomal protein (10 mg/ml). After incubation at 37ºC for 40 minutes, 1 ml of zinc sulfate 
(20%) and 1 ml of saturated barium hydroxide were added to terminate the reaction. After 
centrifugation at 3000 rpm, the formaldehyde was determined spectrophotometrically from 
changes in the color intensity of the supernatant at 415 nm according to the method of Nash 
1953 [36]. The enzymatic activity of NDMA-dI was then expressed as nmol of formaldehyde/mg 
protein/hour. 
Glutathione-S-transferase activity was assayed according to the method of Habig et al 
[37]. The incubation mixture contained 30 μg protein of the supernatant fraction, 0.5 ml of 
glutathione (0.5 mM); 0.1M sodium phosphate buffer, pH 7.3. After preincubation at 37 ºC for 5 
min the reaction was initiated by adding 50 ȝl of 1-chloro-2,4-dinitrobenzene (CDNB; 0.5 mM) 
and incubated at 37 ºC for another 5 min.;  the reaction was terminated  by the addition of 0.2 ml 
of trichloroacetic acid solution (33% w/v). After centrifugation, the CDNB conjugate was 
measured spectrophotometrically in the supernatant at 340 nm. Calculations were made using a 
molar extinction coefficient of 9.6 mM-1 cm-1. A unit of enzyme activity is defined as the 
amount of enzyme that catalyzes the formation of 1 μmole of CDNB conjugate/mg protein/min 
under the assay conditions. Thiobarbituric acid-reactive substances (TBARS) were measured in 
the supernatant of liver tissue homogenates as described by Tapel and Zalkin [38]. The color 
intensity of the TBARS reactants as malondialdehyde was measured at 532 nm and a molar 
extinction coefficient of 156,000 M-1 cm-1 was used for calculation of the TBARS concentration. 
Glutathione levels were estimated in the supernatant of liver tissues homogenates according to 
the method of Mitchell et al [39], using sulfosalicylic acid for protein precipitation and bis-(3-
carboxy-4-nitrophenyl)-disulfide for color development. The color intensity was measured at
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412 nm using a double beam spectrophotometer.Protein concentration was measured as 
described by Lowry et al [40], using bovine serum albumin as standard. Each enzyme assay was 
performed and the mean and standard error were calculated. The data were compared by the 
Student’s t-test using P< 0.05 as the level of significance for all experiments.
Results
The hepatic content of cytochrome P450 was induced after treatment of mice with DMN, 
DEN and MPN by 124, 61, and 44% respectively. While, DMN, DEN, or MPN increased AHH 
activity by 55, 32, and 73% respectively (Table 1). At the same time, cytochrome b5 content 
induced by 55 % and 20% after treatment with DMN or DEN respectively (Table 1). In addition, 
DMN and DEN increased the activity of DMN-dI by 73 and 44% respectively (Table 1).
Interestingly, pretreatment of mice with glutathione prior to administration of DMN and DEN 
was found to restore the activities of the previously mentioned enzymes caused by these 
compounds to their normal levels (Table 1). On the other hand, DMN, DEN, and MPN depleted 
the level of glutathione by 48, 25, and 30% respectively, and increased the levels of free radicals 
(TBARS) by 77, 51, and 53% respectively (Table 2). The activity of GST activity was increased 
by 24 and 99% after administration of DMN and DEN respectively, whereas MPN did not 
change such activity (Table 2). Interestingly, pretreatment of mice with glutathione before 
administration of DMN, or DEN was found to restore the levels of TBARS and GSH to their 
normal levels (Table 2). In addition, GSH pretreatments induced the activity of GST above the 
normal levels after administration of DMN or MPN except DEN did not change such activity 
(Table 2). 
Table 1: Influence of N-nitrosamines on the activity of Phase I carcinogen-metabolizing
enzymes in the liver of male mice before and after treatment with glutathione
Treatments
Variable Control DMN DMN/GSH DEN DEN/GSH MPN MPN/GSH
Cytochrome P450
  [nmolesCyt.P450/mg
 protein]
3.10±0.4 6.95±0.47 
[+124%]*
4.81±0.59
 [+55%]*
5.01±0.53
[+61%]*
3.89±0.75 
  [+25]*
4.46±0.43 
[+44%]*
6.9±0.74
  [+122]*
DMN-N-demethylase I
[nmoles HCHO/mg
 protein/hour]
150.4±12.0 263.0±5.1
[+73%]*
147.5±5.5
     NS
216.0±7.8
[+44%]*
175.5±16.5
     NS
151.0±8.8
NS
195.7±4.5
[+30%]*
Cytochrome b5
[nmolesCyt.b5 /mg 
protein]
1.933±0.4 3.01±0.45
[+55%]*
1.42±0.22
[-26%]*
2.30±0.05
[+20%]*
2.20±0.07
      NS
1.43±0.16
[-26%]*
3.80±0.8
[+96%]*
AHH
pmoles 3-OH B(a)P/mg
protein/min.
135.6±6.6 202.9±9.0
[+55%]*
166±17.2
     NS
186.0±15.8
[+32%]*
160.0±13.2
      NS
236.0±2.7
[+73%]*
275.0±25.5
[+102%]*
* P <0.05. Values are preented as mean ±
Abbreviations: DMN, dimethylnitrosamine,  
Cytochrome P450 content was expressed as n moles Cyp.P450/mg protein
     Cytochrome b5 content was expressed as n moles Cyt.b5/mg protein. DMN-N-demethylase I activity was expressed as n moles 
     HCHO/mg protein/hour. Aryl hydrocarbon hydroxylase activity was expressed as p moles 3-OH
B[a] P/mg protein/min
NS=non-significant
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Table 2: Influence of N-nitrosamines on the activity of glutathione S-transferase,
and levels of glutathione and free radicals in the liver of male mice before
and after treatment with glutathione
Treatments
Variable
Control DMN DMN/GSH DEN DEN/GSH MPN MPN/GSH
Glutathione S-transferase
[Unit/mg protein]
1.56±0.06 1.94±0.01
[+24%]*
2.2±0.24
[+41%]*
3.11±0.03
[+99%]*
1.70±0.15
NS
1.56±0.13
NS
1.91±0.14
[+22%]*
Glutathione
[μ mole GSH/g liver]
6.47±0.66 3.36±0.53
[-48%]*
5.60±0.50
NS
4.85±0.4
[-25%]*
5.16±0.49
NS
4.58±0.49
[-30%]*
5.92±0.53
NS
Free radicals
[μ mole TBARS/g liver]
7.8±0.63 13.8±0.92
[+77%]*
9.0±0.78
NS
11.8±1.6
[+51%]*
8.80±0.61
NS
12.0±0.45
[+53%]*
10.3±1.3
[+32%]*
P <0.05
Glutathione level was expressed as m mole GSH/g. tissue
Glutathione S-transferase activity was expressed as Unit/mg protein
A unit of enzyme activity is defined as the amount of enzyme that catalyzes the formation of 1 mmole of CDNB conjugate/mg protein/min. 
Thiobarbituric acid reactive substance level was expressed as micro mole TBARS/g. tissue
NS=non-significant
Discussion
Treatments of male mice with dimethylnitrosamine, diethylnitrosamine, or 
methylpropylnitrosamine were found to increase the total hepatic content of cytochrome P450, 
as well as the activities of DMN-dI, and AHH (table 1). Interestingly, pretreatment of mice with 
GSH prior to administration of DMN or DEN was found to reduce the increase in the activities 
of these enzymes (table 1). On the other hand, pretreatment of mice with GSH before 
administration of MPN induced the activity of AHH, DMN-dI, and total cytochrome P450 (table 
1). It is noticed that restoring in the enzymatic activity of AHH, DMN-dI and cytochrome P450 
by GSH pretreatment is mainly dependent on the chemical structure of N-nitrosamines. The 
toxic and carcinogenic effects of B[a]P and DMN and DEN compounds are dependent on the 
level of their corresponding bioactivating enzymes [41,42]. Therefore, it is expected that GSH 
could reduce the toxicity and/or carcinogenicity of benzo[a]pyrene, dimethylnitrosamine, and 
diethylnitrosamine. Supporting our finding, it has been found that consumption of food rich in 
GSH content is associated with about a 50% reduction in risk of oral and pharyngeal cancer [28].
Decreasing of cytochrome P450 content and DMN-N-dI activity could play a significant role in 
the reduction of tumorigenicity and carcinogenicity of N-nitroso compounds. Supporting these 
suggestions, it has been shown that the administration of diallylsulfide [DAS], the active 
ingredient of garlic, was found to decrease the tumorgenicity and the level of DNA adduct (O6-
methyldeoxyguanosine) in different organs of rats pretreated with nitrosomethylbenzylamine, N-
methyl-N-nitrosourea, or N-nitrosodimethylamine [43-45]. Moreover, vitamins C or E reduced the 
mutagenic effects of some heterocyclic amines [46] and also decreased the incidence of 
pancreatic cancer caused by N-nitrosobis-2-oxo-propylamine [47].
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The mechanism of induction of AHH activity and cytochrome P450 after N-nitrosamines 
treatment might be due to the presence of (Ah) receptor which has been found in the hepatic 
cytosol of mice [13]. This receptor binds avidly but noncovalently with the inducing agents and 
induces cytochrome P-450 isozymes [13]. In addition, cytochrome P450 system induction might 
be also due to enhancing of delta-aminolevulinic acid (GALA) synthase, the initial and rate-
limiting step in the biosynthesis of the heme moiety of cytochrome P450s or may be due to 
inhibition of heme oxygenase, the first and rate-limiting enzyme in heme degradation, since 
P450s are hemoproteins [13]. 
Non-enzymatic antioxidants such as reduced glutathione (GSH) normally counteract 
damaging effects of intracellular reactive oxygen species [ROS] by either repairing the oxidative 
damage or directly scavenging oxygen radicals [48,49]. The balance between phase I carcinogen 
activating enzymes and phase II carcinogen detoxifying enzymes is important in determining the 
risk of developing chemically-induced cancer [50]. In the present study, DMN, DEN, MPN were 
found to deplete the levels of reduced glutathione and induced the levels of free radicals (Table 
2). In agreement with the present study, it has been found that DMN increased the levels of free 
radicals in the livers of rats [51]. However, pretreatment with N-acetylcysteine, a glutathione 
precursor, was found to reduce the level of free radicals in DMN-treated rats [51]. In the present 
study, DMN and DEN induced the activity of GST, whereas MPN did not change such activity 
(Table 2). Fortunately, pretreatment of mice with GSH prior to administration of N-nitrosamines 
restored the depleted GSH levels and the induced free radical levels to their normal levels (Table 
2). It is well known that GSH depletion could promote tumor development through a mechanism 
that involves cytotoxicity. In addition, depletion of cellular glutathione levels by buthionine 
sulfoximine was found to increase the cytotoxicity, the frequency of sister chromatid exchange 
and prolonged the cell cycle. Therefore, the mechanism of GSH protection against N-
nitrosamines toxicity and/or carcinogenicity might be due to clearance of free radicals generated 
by these compounds. Supporting this suggestion, it has been found that dietary GSH enhances 
metabolic clearance of peroxidized lipids [52]. Also, pretreatment of mice with GSH prior to 
administration of DMN or MPN was found to induce GST activity (Table 2). Therefore, the 
mechanism of GSH protection against N-nitrosamine toxicity is not only for scavenging of free 
radicals but also due to induction of GST activity (Table 2).
It is concluded that N-nitrosamines could initiate their toxic or carcinogenic effects either 
by induction of cytochrome P450 system, depletion of GSH or production of free radical levels. 
Pretreatment of mice with GSH before administration of N-nitrosamines could alleviate partially 
or completely the toxic effects of N-nitrosamines by restoring the activity of carcinogen-
metabolizing enzymes and/or direct binding to the xenobiotic molecules. Our findings are in 
harmony with the concept that consumption of food rich in sufficient sufhydryl groups could 
protect the body against environmental carcinogens.
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